Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
3.
Arch Mal Coeur Vaiss ; 88(12): 1869-74, 1995 Dec.
Article in French | MEDLINE | ID: mdl-8729368

ABSTRACT

The authors report 8 cases of regular tachycardia with wide QRS complexes during treatment with Vaughan-Williams class 1 antiarrhythmic drugs. These antiarrhythmics, prescribed to prevent atrial fibrillation (3 patients) and atrial flutter (5 patients), were flecainide in 4 cases, propafenone in 2 cases and cibenzoline and hydroquinidine respectively associated with digitoxine and propranolol. These wide complex tachycardias were regular atrial tachycardias with 1/1 conduction to the ventricle. The action of the drug, more pronounced on intra-atrial conduction velocities than on atrioventricular node refractoriness resulted in transformation of flutter at 300 cycles/min with 2/1 conduction and a ventricular rate of 150 cycles/min to atrial flutter at 210 cycles/min with 1/1 ventricular conduction. This acceleration of the ventricular rate was accompanied by widening of the QRS complex. Using the new ventricular tachycardia criteria recently published by Brugada resulted in a diagnostic error in 7 out of the 8 cases. The recording of a wide QRS complex tachycardia in a patient on class 1 antiarrhythmic therapy for an atrial arrhythmia should alert the physician to 1/1 atrial tachycardia despite morphological electrocardiographic criteria of ventricular tachycardia. The 1/1 atrial tachycardia may be poorly tolerated and require emergency treatment. The preventive association of a drug which slows conduction through the atrioventricular node is not always effective.


Subject(s)
Anti-Arrhythmia Agents/adverse effects , Tachycardia, Supraventricular/chemically induced , Adult , Aged , Aged, 80 and over , Anti-Arrhythmia Agents/therapeutic use , Atrial Fibrillation/prevention & control , Atrial Flutter/prevention & control , Drug Therapy, Combination , Electrocardiography , Female , Flecainide/adverse effects , Flecainide/therapeutic use , Heart Rate/drug effects , Humans , Imidazoles/therapeutic use , Male , Middle Aged , Propafenone/adverse effects , Propafenone/therapeutic use , Tachycardia, Supraventricular/physiopathology , Tachycardia, Supraventricular/prevention & control
4.
Arch Mal Coeur Vaiss ; 86(3): 363-7, 1993 Mar.
Article in French | MEDLINE | ID: mdl-8215772

ABSTRACT

The authors report the first case of arrhythmogenic right ventricular dysplasia presenting with a sudden death due to primary ventricular fibrillation (ventricular fibrillation not preceded by ventricular tachycardia) recorded by the Holter method. The patient was a 56 year old man whose only complaint was near syncopal case is the fact that it is the first documented case of ventricular fibrillation revealing arrhythmogenic right ventricular dysplasia, the diagnosis of which was made at autopsy. In addition, the Holter recording showed the factors which triggered the arrhythmia: the "trigger" of 4 monomorphic ventricular extrasystoles during the minute preceding the ventricular fibrillation; the arrhythmogenic substrate giving rise to late ventricular potentials and, finally, the analysis of the R-R intervals suggesting a role of the sympathetic and parasympathetic nervous systems. Holter recordings could help identify subjects at high risk of severe ventricular arrhythmias.


Subject(s)
Cardiomyopathies/complications , Death, Sudden, Cardiac/etiology , Electrocardiography, Ambulatory , Heart Ventricles/pathology , Ventricular Fibrillation/complications , Adipose Tissue/pathology , Arrhythmias, Cardiac/complications , Arrhythmias, Cardiac/diagnosis , Cardiomyopathies/pathology , Death, Sudden, Cardiac/pathology , Humans , Male , Middle Aged , Risk Factors , Ventricular Fibrillation/diagnosis , Ventricular Function, Right
SELECTION OF CITATIONS
SEARCH DETAIL
...